BMP2 and malignant peripheral nerve sheath tumor: A likely explanation of the synergistic interaction of LDN-193189 and selumetinib in MPNST cells is by cross-talk of BMP2-SMAD1/5/8 and MEK-ERK pathways via another signaling pathway.